ASCO 2022: Cell-free DNA methylation used to predict chemo benefit in bladder cancer
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded…
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded…
Tumours from desmoplastic melanoma, a rare cancer most commonly found on the head or neck,…
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or…
A novel combination of two experimental cancer immunotherapy agents along with an immune checkpoint blocker…
A new genomic test designed to measure endocrine sensitivity of estrogen receptor-positive breast cancer has…
To fully evaluate hormone-blocking therapy following surgery for patients with early-stage high-risk HR+/HER2- breast cancer,…
Nearly one million people in the United States are affected by Lynch syndrome – a…
Combination immunotherapy treatment with anti-PD-1 and anti-CTLA-4 checkpoint inhibitors has proven effective as a front-line option for many patients…
Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer caused by…
Most head and neck cancer patients treated with radiation therapy develop long-term treatment-related dry mouth, or xerostomia,…